Results 221 to 230 of about 678,448 (346)

The Misdiagnosis and Underdiagnosis of Hepatic Encephalopathy. [PDF]

Clin Transl Gastroenterol
Bloom PP.
europepmc   +1 more source

Current insights into pathogenesis and anti‐inflammatory treatment strategies for severe alcohol‐associated hepatitis: focus on neutrophil‐targeted therapies

Hepatology Research, EarlyView.
Abstract Alcohol‐associated hepatitis (AH) is the leading cause of liver‐related mortality, with severe alcohol‐associated hepatitis (SAH) showing a short‐term mortality rate of 20%–50% even in developed countries. Corticosteroids are the only evidence‐based pharmacologic treatment, but their efficacy is limited to short‐term survival, with 30%–40% of ...
Ryosuke Kasuga, Po‐Sung Chu, Takanori Kanai, Nobuhiro Nakamoto   +3 more
wiley   +1 more source

Efficacy and safety of rifaximin in preventing hepatic encephalopathy: A systematic review and meta-analysis. [PDF]

PLoS One
Hu Y, Zhang X, Xiao Y, Wu Z, Wang Y.
europepmc   +1 more source

Adaptation and Validation of the Supportive and Palliative Care Indicators Tool (SPICT): A Quantitative Methodological Study

Journal of Advanced Nursing, EarlyView.
ABSTRACT Aims To translate the Supportive and Palliative Care Indicators Tool (SPICT) into Chinese and conduct preliminarily tests of its performance in hospitalized patients with cancer. Design A cross‐sectional validation study conducted from January to March 2024.
Yufei Huang, Cunqing Deng, Haiyang Lin, Meifang Peng, Yanping Hao   +4 more
wiley   +1 more source

Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024). [PDF]

J Clin Transl Hepatol
Xu X, Ding H, Li W, Han Y, Guan Y, Xu J, Han Y, Jia J, Wei L, Duan Z, Nan Y, Zhuang H, Chinese Society of Hepatology, Chinese Medical Association.   +13 more
europepmc   +1 more source

Delirium in the Acute Care Setting From the Families Perspective: A Scoping Review

Journal of Advanced Nursing, EarlyView.
ABSTRACT Aim To explore the existing literature on delirium within the acute care setting from the family members' perspective and summarise key findings. Design A scoping review guided by Arksey and O'Malley's methodological framework and refined by the Joanna Briggs Institute.
Amber Mclean, Beverley Ewens, Amanda Towell‐Barnard   +2 more
wiley   +1 more source

Chemotactic Zn micromotor for treatment of high blood ammonia-associated hepatic encephalopathy. [PDF]

Nat Commun
Feng Y, Gao C, Peng X, Chen B, Ding M, Du D, Rong J, Lv Q, Wilson DA, Tu Y, Peng F.   +10 more
europepmc   +1 more source

Patient Agitation in the Intensive Care Unit: A Concept Analysis

Journal of Advanced Nursing, EarlyView.
ABSTRACT Aim Exploring the concept of patient agitation in the intensive care unit. Background Patient agitation in the intensive care unit is of widespread concern and linked to negative outcomes for patients, staff, and family members. There is currently no consensus on what constitutes agitation in the intensive care context, hindering effective and
Anne Mette N. Adams, Diane Chamberlain, Charlotte Brun Thorup, Matthew J. Maiden, Cherie Waite, Hila Ariela Dafny, Kay Bruce, Tiffany Conroy   +7 more
wiley   +1 more source

Letter to the editor: Refining risk stratification in hepatic encephalopathy-External validation of the BABS score in European cohorts. [PDF]

Hepatol Commun
Østberg NG, Berg-Beckhoff G, Grønkjær LL, Jonasson E, Schleicher EM, Gairing SJ, Labenz C, Lauridsen MM.   +7 more
europepmc   +1 more source

Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 2 study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Patients with alopecia areata received etrasimod 2 mg, 3 mg or placebo oncedaily for 24 weeks, followed by a 28‐week open‐label extension period. Overall, etrasimod 2 mg and 3 mg were safe and well tolerated in patients; their efficacy was numerically higher than placebo and appeared to be dose dependent.
B. King, N. Mesinkovska, M. Senna, X. Luo, J. Minkiewicz, A. Selfridge   +5 more
wiley   +1 more source